Natalie Raphael was diagnosed as having glucokinase MODY at the end of her first pregnancy. In her second pregnancy she had a recently introduced blood test that showed her fetus had not inherited her change in the glucokinase gene so was at risk of growing large. As a result of this she was given long-acting insulin to lower her glucose. Alice Hughes is the researcher who during her PhD did the key study that proved the new blood test was both practical and accurate in glucokinase pregnancy.
Natalie Raphael was surprised to be diagnosed with gestational diabetes in her first pregnancy despite being slim and active. Despite changing her diet drastically her fasting blood sugar remained raised, and she was started on metformin tablets and insulin injections. Even with high doses of insulin her morning glucose remained high. Just before she delivered, she was diagnosed as having glucokinase MODY which explained her high glucose and the limited response to treatment by diet and insulin. Her first son was born at a normal weight slightly early.
Natalie rapidly became pregnant again. This time the cause of her raised fasting glucose was known to be due to the change in the glucokinase gene so no initial treatment for the raised glucose was given. She was the first person in the routine Exeter clinic to have the blood test (cell free DNA) that determines in pregnant glucokinase mothers if the fetus has inherited their genetic change. In this pregnancy the test showed the fetus had not inherited the glucokinase mutation and so was at risk of being large at birth. Natalie was therefore treated with long acting overnight insulin in the last third of pregnancy and her second son was a normal birth weight.
This shows her glucose values during her second pregnancy – these results are typical for glucokinase.


Alice Hughes trained initially in obstetrics and gynaecology and came to Exeter to study for a Wellcome Trust funded GW4 PhD looking at how the fetus grows in the womb and how the maternal and fetal genes influence this.
This is a link about her work:
https://medicine.exeter.ac.uk/clinical-biomedical/people/profile/index.php?username=aeh221
Alice did the first study of using the glucokinase cell free DNA test on mother’s blood in pregnancy to see if the fetus had inherited the change in the glucokinase gene from their mothers. She found it was a practical and accurate test that could be used to guide how to treat the mother.
This is a link to the paper
https://pubmed.ncbi.nlm.nih.gov/37653058/
The highly accurate method was developed by Richard Caswell and Prof Sian Ellard and their first paper is here.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7611030/
A link to more information about cell free DNA genetic testing in families with Glucokinase or HNF4A MODY is found here